Compare TEX & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TEX | TFX |
|---|---|---|
| Founded | 1933 | 1943 |
| Country | United States | United States |
| Employees | 10700 | N/A |
| Industry | Construction/Ag Equipment/Trucks | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2B | 5.8B |
| IPO Year | 1994 | 1994 |
| Metric | TEX | TFX |
|---|---|---|
| Price | $64.53 | $134.62 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 8 |
| Target Price | $68.80 | ★ $138.75 |
| AVG Volume (30 Days) | ★ 1.4M | 390.5K |
| Earning Date | 05-01-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.12% | 1.02% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,421,000,000.00 | $1,992,713,000.00 |
| Revenue This Year | $47.67 | $15.97 |
| Revenue Next Year | $6.66 | $5.15 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 5.73 | N/A |
| 52 Week Low | $41.70 | $100.18 |
| 52 Week High | $74.69 | $139.67 |
| Indicator | TEX | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 47.07 | 55.58 |
| Support Level | $58.54 | $126.25 |
| Resistance Level | $66.33 | $136.86 |
| Average True Range (ATR) | 3.05 | 4.18 |
| MACD | -0.68 | 0.24 |
| Stochastic Oscillator | 18.36 | 61.09 |
Terex is a global manufacturer of aerial work platforms, materials processing equipment, and specialty equipment for the waste, recycling, and utility industries. Its current composition is a result of numerous acquisitions over several decades to focus on a smaller group of light construction and other vocational equipment, having divested a handful of underperforming businesses, particularly in cranes and other lifting equipment. These remaining segments see heavy demand in nonresidential construction (aerial work platforms—40% sales), aggregates/mining (materials processing—30% sales), environmental, waste/recycling and utilities (environmental solutions group—30% sales).
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.